SHR-902275

N/A

Report date: 2022/02/15 16:47:23
NME

Base Information

Drug NameSHR-902275
Drug Alias NameSHR-902275
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRAF serine/threonine protein kinase inhibitors
TargetsRAF serine/threonine protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEternity Bioscience IncShanghai Hengrui Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEternity Bioscience IncShanghai Hengrui Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A